Drug therapy for the elderly
With people aged 65 years and older currently making up the fastest growing age group throughout the world, the demographic revolution of an aging society will inevitably lead to increased pressure to develop a rationalistic and age-tailored process of diagnosis and treatment among the elderly. As a...
Saved in:
| Other Authors: | |
|---|---|
| Format: | Book/Monograph |
| Language: | English |
| Published: |
Vienna
Springer
2013
|
| Series: | SpringerLink Bücher
|
| DOI: | 10.1007/978-3-7091-0912-0 |
| Subjects: | |
| Online Access: | Verlag, Volltext: https://doi.org/10.1007/978-3-7091-0912-0 Resolving-System, lizenzpflichtig, Volltext: http://dx.doi.org/10.1007/978-3-7091-0912-0 Cover: https://swbplus.bsz-bw.de/bsz373430396cov.jpg 
|
| Author Notes: | edited by Martin Wehling |
Table of Contents:
- Drug Therapy for the Elderly; Foreword; Preface; Contents; About the Editor; List of Contributors; General Aspects; Heterogeneity and Vulnerability of Older Patients; Pharmacotherapy Between Individualization and Standardization; Important Aspects of Differential Pharmacotherapy in the Elderly; Adverse Drug Reactions; Multimorbidity; Frailty; Functionality and the Concept of Activities of Daily Living; Reduced Life Expectancy; Geriatric Syndromes; Evaluation of Different Approaches to Describe Heterogeneity and Vulnerability in the Elderly; References; Epidemiologic Aspects
- Definition of the ElderlyMethodological Aspects; General Aspects; Functionality, Frailty, and Multimorbidity; Adverse Drug Reactions; References; Age-Associated General Pharmacological Aspects; Pharmacokinetics; Special Aspects of Geriatric Pharmacokinetics; Physiological Alterations, with the Kidneys in Focus; Heterogeneity of Elderly Patients and Interactions of Various Aspects of Drug Therapy; Pharmacogenetics and Drug Interactions; Properties and Conditions of Drugs and Drug Combinations that Increase the Risk of Interactions; Drug Groups with a Strong Potential for Interactions
- Adverse Drug ReactionsPharmacodynamics; Plasma Concentrations of Drugs and Clinical Effect; Changes of Target Organs and Metabolism in the Elderly; Therapy Management; Physicians´ Guiding Principles of Drug Therapy in the Elderly; References; Critical Extrapolation of Guidelines and Study Results: Risk-Benefit Assessment for Patients with Reduced Life Expectancy and ...; Extrapolation of Data from Younger to Elderly Patients in Reflection of a Reduced Life Expectancy; Categorization of Drugs with Regard to Their Fitness for the Aged
- Aiding Rationalization by Negative Lists of Drugs for the ElderlyPositive Assessment of Drugs for the Elderly; Proposal of a New Drug Classification Reflecting Utility in the Elderly: Fit for the Aged, FORTA; Use Instructions for the FORTA Classification; References; Inappropriate Medication Use and Medication Errors in the Elderly; Introduction; Suboptimal Prescribing; Underprescribing; Dosing of Renally Cleared Medications; Drug-Drug Interactions; Medication Administration Errors; References; Special Aspects with Respect to Organ Systems Based on Geriatric Clinical Importance
- Arterial HypertensionRelevance for Elderly Patients, Epidemiology; Therapeutically Relevant Special Features of Elderly Patients; Systolic Hypertension; Additional Age-Related Alterations of Relevance for Antihypertensive Therapy; Evidence-Based, Rationalistic Drug Therapy and Classification of Drugs According to Their Fitness for the Aged (FORTA); Diuretics; Beta-Blockers; ACE Inhibitors/Angiotensin Receptor Antagonists; Dihydropyridine Calcium Channel Blockers; General Rules for the Antihypertensive Treatment of Elderly Patients
- Classification of Antihypertensive Drugs According to Their Fitness for the Aged (FORTA)